Partial agonists in schizophrenia [1]

British Journal of Psychiatry

Volumn 186, Issue APR., 2005, Pages 354-

  Cousins, D A ^a   Young, A H ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT; PARTIAL AGONIST;

BINDING AFFINITY; DRUG ANTAGONISM; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; LETTER; NEUROTRANSMISSION; PSYCHOSIS; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; RELAPSE; SCHIZOPHRENIA; SUPERSENSITIVITY;

EID: 17144366945     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.186.4.354     Document Type: Letter

References (5)

1. Bolonna, A. A. & Kerwin, R.W. (2005) Partial agonism and schizophrenia. British Journal of Psychiatry, 186, 7-10.
2. DeLeon, A., Patel, N. C. & Crismon, M. L. (2004) Aripiprazole: A comprehensive review of its pharmacology, clinical efficacy, and tolerability. Clinical Therapeutics, 26, 649-666.
3. DeQuardo, J. R. (2004) Worsened agitation with aripiprazole: adverse effect of partial agonism? Journal of Clinical Psychiatry, 65, 132-133.
4. Ramaswamy, S., Vijay, D., William, H., et al (2004) Aripiprazole possibly worsens psychosis. International Clinical Psychopharmacology, 19, 45-48.
5. Steiner, W., Laporta, H. & Chouinard, G. (1990) Neuroleptic-induced supersensitivity psychosis in patients with bipolar affective disorder. Acta Psychiatrica Scandinavica, 81, 437-440.